Unidym Spins Off Ensysce Biosciences
Menlo Park-based Unidym said today that it has spun off a new company, Ensysce Biosciences, focused on research into the medical therapeutic applications of carbon nanotubes. According to Unidym, it has licensed its nanotechnology patent portfolio to Ensysce and will hold a significant equity position in the new company. Unidym said the deal also includes up-front licensing deals and royalties from Ensysce in exchange for its licenses. Unidym reported that an unnamed angel investor is backing Ensysce
posted on Tuesday, March 18, 2008
Related companies:
Unidym
Related stories:
> Unidym Sold To Korean Firm
> Unidym Gets $10.4M
> Unidym Gets $4M In Funding
> 3-V Biosciences Finds $20M In Funding
> Pacific Biosciences Raises $50M
silicontap.com Home